FINZALA
DEAD

Serial Number

97110329

Owner

Teva Pharmaceuticals USA, Inc.

Attorney

Laurence Rickles

Filing Date

Nov 5, 2021

Add to watchlist:

No watchlists yet
View on USPTO

FINZALA Trademark

Serial Number: 97110329

FINZALA is a trademark filed by Teva Pharmaceuticals USA, Inc. on November 5, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Teva Pharmaceuticals USA, Inc. (587 trademarks)

650 Cathill Road
Sellersville, PA 18960

Entity Type: 03

Trademark Details

Filing Date

November 5, 2021

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations for the treatment of alimentary, anti-parasitic, autoimmune, blood-related, cancer, cardiovascular, central nervous system, dermatological, endocrine, gastrointestinal, immunological, infectious, inflammatory, menopausal, musculo-skeletal, neurological, opthalmological, pain, renal, metabolic, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for use in hematology

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jun 27, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jun 27, 2025 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 8, 2025 GNRN
NON-FINAL ACTION E-MAILED
Feb 8, 2025 GNRT
NON-FINAL ACTION WRITTEN
Feb 8, 2025 CNRT
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Nov 20, 2024 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Feb 16, 2024 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Aug 16, 2023 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 30, 2023 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 25, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
May 25, 2022 GNSL
SUSPENSION LETTER WRITTEN
May 25, 2022 CNSL
ASSIGNED TO EXAMINER
May 25, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 15, 2021 NWOS
NEW APPLICATION ENTERED
Nov 9, 2021 NWAP